Treatment with 9cRA or the synthetic RXR agonist LGD1069 (bexarotene) has been shown to reduce oxidative stress-induced cell damage and preserve the mitochondrial membrane potential.407 In heart failure, oxidative stress activates angiotensin-II (AngII), leading to harmful cardiac remodeling and dysfunction. Here, AGT is linked to heart failure.